Enrich Biosystems Inc.
Branford, CT
- UEI
- M6XYEESK8AS8
- CAGE
- 86RU0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 21 Business Park Dr, Branford, CT 06405, USA
- Website
- enrichbiosystems.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase I topic #439 - advanced sample processing platforms for downstream single-cell multi-omic analysis | National Cancer Institute (NIH) | $399,761 |
Grant awards
Similar vendors
About the company
Enrich Biosystems Inc. is a corporate entity registered in the federal System for Award Management (SAM.gov) to conduct business with the U.S. government. The company develops advanced platforms for single-cell multi-omic analysis to support biomedical research and accelerate precision medicine.
Enrich Biosystems Inc. has received federal contract awards from agencies like the National Institutes of Health (NIH) National Cancer Institute to develop innovative technologies for single-cell analysis. In September 2022, the company was awarded a $454,751 firm fixed price definitive contract under the Small Business Innovation Research (SBIR) Program Phase I to develop advanced sample processing platforms for downstream single-cell multi-omic analysis. The 24-month research project aims to advance the NIH's mission of biomedical research and precision medicine efforts.
Through federal grant awards from agencies such as the NIH National Institute of Allergy and Infectious Diseases, Enrich Biosystems Inc. has conducted research on single-cell isolation and analysis platforms. The company received a $3,334,180.56 project grant in August 2020 for "Single Clone Discovery Using an Image-Based Cell Isolation Platform," which ran through July 2022. Additionally, Enrich Biosystems Inc. was awarded a $186,372.09 project grant in June 2019 for the same research project, which lasted until May 2020. These grants have supported the development of innovative technologies for isolating and analyzing single cells, contributing to advancements in areas like infectious disease research.
Quick answers
Is Enrich Biosystems Inc. registered in SAM.gov?
Yes. Enrich Biosystems Inc.'s SAM.gov registration is active through May 4, 2027.
What is Enrich Biosystems Inc.'s CAGE code?
Enrich Biosystems Inc.'s CAGE code is 86RU0, and its Unique Entity ID (UEI) is M6XYEESK8AS8.
What is Enrich Biosystems Inc.'s most recent federal award?
Enrich Biosystems Inc.'s most recent federal contract award is Sbir phase I topic #439 - advanced sample processing platforms for downstream single-cell multi-omic analysis (75N91022C00061), from National Cancer Institute (NIH), on September 19, 2022.
On GovTribe
See Enrich Biosystems Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors